Global Preimplantation Genetics Diagnosis (PGD) Market

1
Global Preimplantation Genetics Diagnosis (PGD)
Market 2018 2025

• Published By
• Accurize Market Research

2
Global Preimplantation Genetics Diagnosis (PGD)
Market is Estimated to Reach 140 Million by
2024, Says Accurize Market Research

• Global Preimplantation Genetics Diagnosis
  (PGD)Market report published by Accurize Market
  Research forecast that the global market is
  expected to reach 140 Million by 2024 growing
  at a CAGR of 6.2 from 2017 to 2025. By
  geography, Asia Pacific and North America are
  expected to grow at a CAGR of XX and XX,
  respectively, during the forecast period.
• Request Sample
• https//www.accurizemarketresearch.com/report/prei
  mplantation-genetics-diagnosis--pgd--market/sample
  -request

3

• Increasing occurrence of genetic disorders to
  drive the global market
• Some of the factors driving the growth of the
  global preimplantation genetics diagnosis (PGD)
  market are declining fertility rate, advancements
  in the field of genetic analysis, increasing
  occurrence of genetic disorders, rising demand of
  IVF treatments, and high possibility of genetic
  abnormalities in embryos with progressing
  maternal age.
• Factors such as stringent government regulations
  and social-economic concerns would limit the
  growth of the market.
• However, rising RD and market expansion would
  provide market opportunities in the coming years.
• Ask for customization
• https//www.accurizemarketresearch.com/report/prei
  mplantation-genetics-diagnosis--pgd--market/ask-fo
  r-customization

4
Market Segmentation

• Test type and geography are the major
  bifurcations in the global preimplantation
  genetics diagnosis (PGD) market.
• Test type is further categorized as gender
  selection, chromosomal abnormalities, single gene
  disorders, HLA typing, Aneuploidy, X-linked
  diseases, and other test types.
• North America, Europe, Asia-Pacific and rest of
  the world (RoW) are the geographical segments of
  the market.
• North America is further bifurcated into
  countries namely U.S., Canada and Mexico.
• Europe covers countries like Russia, U.K.,
  Germany, France, Italy and Rest of Europe.
  Asia-Pacific countries include China, India,
  Japan, South Korea and Rest of Asia Pacific.
• Rest of the World (RoW) covers South America,
  Africa and Middle East.

5

• "Chromosomal abnormalities accounted for the
  largest market share in the type segment", says
  Accurize
• Chromosomal abnormalities accounted the largest
  market share, whereas, other test types shall
  attain the fastest CAGR during the forecast
  period 20172025.
• "North America dominated the global market with
  the highest market share over the forecast
  period", says Accurize
• Europe and North America accounted the maximum
  market share in 2017, with 31.5 and 26.8
  respectively. In terms of growth, North America
  would dominate with fastest CAGR during the
  forecast period, driven by, high awareness among
  people regarding availability of such treatment,
  increasing infertility rate, and rising
  investments by government organizations.

6
Top players in the market

• Major companies operating in the market include
• Abbott Laboratories
• Natera Inc.
• PerkinElmer Inc.
• Illumina Inc.
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific, Inc.
• Agilent Technologies, Inc.
• PerkinElmer Inc.
• Cooper Surgical Inc. and
• Beijing Genomics Institute (BGI) among others.

7
Contact Us

• Accurize Market Research Pvt. Ltd.
• PUNE OFFICE 306
• ZEN BUSINESS CENTER
• WAKAD, NEAR BHUMKAR CHOWK
• MUMBAI BANGALORE HIGHWAY
• PUNE-411057
• Email help_at_accurizemarketresearch.com
• Contact No 1-339-368-6383